Mario Alberto Accardi Centessa Pharmaceuticals PLC (CNTA) insider trading activity
Mario Alberto Accardi is President, Orexin Program of Centessa Pharmaceuticals plc. Currently has a direct ownership of 216,485 shares of CNTA, which is worth approximately $3.05 Million. The most recent transaction as insider was on Jun 24, 2025, when has been sold 15,000 shares (Ordinary Shares) at a price of $14.0 per share, resulting in proceeds of $210,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
216K
n/a
3M change
n/a
12M change
Total Value Held
$3.05 Million
Mario Alberto Accardi Transaction History
MAA
Mario Alberto Accardi
President, Orexin Program
Cheshire, X0